Northwell Health was one of many who conducted a pioneering clinical trial to treat rheumatoid arthritis through a chip implanted on the vagus nerve. The first technology of its kind yielded ...
The MarketWatch News Department was not involved in the creation of this content. Milestone underscores continued momentum in commercial rollout and accelerating adoption of neuroimmune modulation as ...
Lovell Government Services and SetPoint Medical partner to deliver FDA-approved neuroimmune therapy for rheumatoid ...
Hosted on MSN
How a one-minute jolt from the SetPoint implant offers new hope for autoimmune disease patients
The US Food and Drug Administration (FDA) recently approved a medical device that could bring new hope to patients suffering from rheumatoid arthritis (RA), a chronic autoimmune condition often ...
An innovative new device calms inflammation by delivering a low-voltage jolt of electricity to the vagus nerve. The FDA has approved the SetPoint System, a device implanted in the neck for relieving ...
Credit: SetPoint Medical. The SetPoint System is a rechargeable neurostimulation device that is implanted on the vagus nerve. Treatment with the SetPoint System, a neuroimmune modulation device, was ...
Procedures performed by Dr. Webster Crowley mark a milestone for neuroimmune modulation therapy in the Midwest SetPoint Medical today announced the first patients in Chicago have been treated with the ...
VALENCIA, Calif.--(BUSINESS WIRE)--SetPoint Medical, a clinical-stage healthcare company dedicated to people living with chronic autoimmune diseases, today announced late-breaking data from the ...
Milestone underscores continued momentum in commercial rollout and accelerating adoption of neuroimmune modulation as a new option for adults living with Rheumatoid Arthritis "The SetPoint System ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results